Homologous Recombination Deficiency Testing for BRCA-Like Tumors: The Road to Clinical Validation

por Ladan, Marjolijn M., van Gent, Dik C., Jager, Agnes
Publicado 2021

Ex vivo tumor culture systems for functional drug testing and therapy response prediction

por Meijer, Titia G, Naipal, Kishan AT, Jager, Agnes, van Gent, Dik C
Publicado 2017

Regulatory Approval, Reimbursement, and Clinical Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Metastatic Breast Cancer in the Netherlands

por Luyendijk, Marianne, Blommestein, Hedwig, Uyl-de Groot, Carin, Siesling, Sabine, Jager, Agnes
Publicado 2023

Integrative whole-genome and transcriptome analysis of HER2-amplified metastatic breast cancer

por Verschoor, Noortje, Smid, Marcel, Jager, Agnes, Sleijfer, Stefan, Wilting, Saskia M., Martens, John W. M.
Publicado 2023

Hospital-based or home-based administration of oncology drugs? A micro-costing study comparing healthcare and societal costs of hospital-based and home-based subcutaneous administr...

por Franken, Margreet, Kanters, Tim, Coenen, Jules, de Jong, Paul, Jager, Agnes, Groot, Carin Uyl-de
Publicado 2020

Neutrophil-guided dosing of anthracycline–cyclophosphamide-containing chemotherapy in patients with breast cancer: a feasibility study

por Drooger, Jan C., van Pelt-Sprangers, Johanna M., Leunis, Corry, Jager, Agnes, de Jongh, Felix E.
Publicado 2015

A Systematic Review of the Use of Circulating Cell-Free DNA Dynamics to Monitor Response to Treatment in Metastatic Breast Cancer Patients

por Jongbloed, Elisabeth M., Deger, Teoman, Sleijfer, Stefan, Martens, John W. M., Jager, Agnes, Wilting, Saskia M.
Publicado 2021

Cost-Effectiveness Analysis of MammaPrint(®) to Guide the Use of Endocrine Therapy in Patients with Early-Stage Breast Cancer

por Luyendijk, Marianne, Jager, Agnes, Buijs, Sanne M., Siesling, Sabine, Groot, Carin A. Uyl-de, Blommestein, Hedwig M.
Publicado 2023

Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer

por Drooger, Jan C., Heemskerk-Gerritsen, Bernadette A. M., Smallenbroek, Nyrée, Epskamp, Cynthia, Seynaeve, Caroline M., Jager, Agnes
Publicado 2016

Triple-Negative Breast Cancer and Predictive Markers of Response to Neoadjuvant Chemotherapy: A Systematic Review

por van den Ende, Nadine S., Nguyen, Anh H., Jager, Agnes, Kok, Marleen, Debets, Reno, van Deurzen, Carolien H. M.
Publicado 2023

The effect of immediate breast reconstruction on the timing of adjuvant chemotherapy: a systematic review

por Xavier Harmeling, J., Kouwenberg, Casimir A. E., Bijlard, Eveline, Burger, Koert N. J., Jager, Agnes, Mureau, Marc A. M.
Publicado 2015

Omitting re-excision for focally positive margins after breast-conserving surgery does not impair disease-free and overall survival

por Vos, Elvira L., Siesling, Sabine, Baaijens, Margreet H.A., Verhoef, Cornelis, Jager, Agnes, Voogd, Adri C., Koppert, Linetta B.
Publicado 2017

Inhibiting CDK4/6 in Breast Cancer with Palbociclib, Ribociclib, and Abemaciclib: Similarities and Differences

por Braal, C. Louwrens, Jongbloed, Elisabeth M., Wilting, Saskia M., Mathijssen, Ron H. J., Koolen, Stijn L. W., Jager, Agnes
Publicado 2020

Tamoxifen use and potential effects on liver parenchyma: A long‐term prospective transient elastographic evaluation

por Braal, C. Louwrens, de Knegt, Robert J., Jager, Agnes, Koolen, Stijn L. W., Mathijssen, Ron H. J., Eechoute, Karel
Publicado 2022

The impact of menstruation persistence or recovery after chemotherapy on survival in young patients with hormone receptor negative breast cancer

por van Barele, Mark, Heemskerk-Gerritsen, Bernadette A.M., van Doorn, Helena C., Schmidt, Marjanka K., Hooning, Maartje J., Jager, Agnes
Publicado 2020

Corrigendum to “The impact of menstruation persistence or recovery after chemotherapy on survival in young patients with hormone receptor negative breast cancer” [Breast 52 (2020)...

por van Barele, Mark, Heemskerk-Gerritsen, Bernadette A.M., van Doorn, Helena C., Schmidt, Marjanka K., Hooning, Maartje J., Jager, Agnes
Publicado 2020

Efficacy of opioid rotation to continuous parenteral hydromorphone in advanced cancer patients failing on other opioids

por Oldenmenger, Wendy H., Lieverse, Paul J, Janssen, Paul J. J. M., Taal, Walter, van der Rijt, Carin C. D., Jager, Agnes
Publicado 2011

Adjuvant radiotherapy for primary breast cancer in BRCA1 and BRCA2 mutation carriers and risk of contralateral breast cancer with special attention to patients irradiated at younge...

por Drooger, Jan C., Akdeniz, Delal, Pignol, Jean-Philippe, Koppert, Linetta B., McCool, Danielle, Seynaeve, Caroline M., Hooning, Maartje J., Jager, Agnes
Publicado 2015

Measuring Quality of Life Using Patient-Reported Outcomes in Real-World Metastatic Breast Cancer Patients: The Need for a Standardized Approach

por Clarijs, Marloes E., Thurell, Jacob, Kühn, Friedrich, Uyl-de Groot, Carin A., Hedayati, Elham, Karsten, Maria M., Jager, Agnes, Koppert, Linetta B.
Publicado 2021

Estrogens and Progestogens in Triple Negative Breast Cancer: Do They Harm?

por van Barele, Mark, Heemskerk-Gerritsen, Bernadette A. M., Louwers, Yvonne V., Vastbinder, Mijntje B., Martens, John W. M., Hooning, Maartje J., Jager, Agnes
Publicado 2021